ERBB2 and non-small cell lung carcinoma: However, other heterogeneous missense mutations in NSCLC in different regions of HER2, such as ECD, TMD, and ICD, have received less attention and investigation regarding their potential for activating HER2 and their responses to currently available HER2-directed TKIs.